Introduction
Bacterial commensals and pathogens are well adapted to the diverse environments found in the human host. Indeed, the primary requirement for bacterial survival is to scavenge nutrients from the host or from other microbes for the bacterial metabolism. While bacterial colonizers of the gastrointestinal tract can take advantage of nutrients from ingested food, bacteria constituting the microbiota of other body surfaces such as skin and mucous membranes of the respiratory or genitourinary tract have to cope with scant carbon and energy sources. Such commensals have to compete successfully with other microbes Zipperer et al., 2016) . In addition, some are facultative pathogens producing virulence factors that contribute to invasion and infection. Accordingly, interfering with their metabolism may help to prevent pathogen colonization.
Staphylococcus aureus is part of the normal microbiota of the anterior nares in around 30% of the human population without causing any disease but also a relevant pathogen when breaches of the skin or epithelial barriers allow access to sterile tissues (Wertheim et al., 2005; Weidenmaier et al., 2012) . S. aureus can cause a variety of infections, most notably skin, soft tissue, bone, and bloodstream infections and its capacity to acquire resistance to antibiotics such as ß-lactams aggravates its pathogenic potential (Otto, 2012) . In atopic dermatitis patients, S. aureus represents also a frequent colonizer of other parts of the skin (Gong et al., 2006) . Methicillinresistant S. aureus can also survive for long periods on abiotic surfaces outside of the human body, which promotes their dissemination in healthcare environments. Surface and secreted proteins relevant to pathogenicity have been characterized, but a lack of information exists concerning survival factors needed for the uptake of nutrients. Indeed, the ability to survive depends on capacities to metabolize a variety of different nutrient sources from diverse niches (e.g., in body fluids and tissues) (Brown et al., 2008) .
Recent studies have shown that the human nose is an extremely nutrient-poor environment and that S. aureus upregulates many biosynthetic pathways under colonization conditions because only limited amounts of building blocks can be obtained from environmental sources (Krismer et al., 2014) . Glucose and other sugars are found in body fluids but their amounts vary drastically between tissues and donors, possibly as a consequence of individual differences in diet and food intake frequency. Notably, it has remained unknown, which molecules may represent the main energy and carbon sources for S. aureus when major nutrient levels fluctuate. S. aureus is known to secrete a variety of hydrolytic enzymes, probably as a means to mobilize nutrients from host cell polymers. These enzymes include the S. aureus nuclease, phospholipase C, sphingomyelinase, lipases, and a variety of proteases (Kusch and Engelmann, 2014) . In addition, S. aureus secrets the GlpQ protein (Ziebandt et al., 2004) , which shares sequence similarity with several bacterial glycerophosphodiesterases (glycerophosphodiester phosphodiesterase, EC 3.1.4.46). GlpQ has been previously found to be a highly immunodominant protein in bacteraemia patients (Kolata et al., 2011) , but its physiological role has remained unknown.
We hypothesized that GlpQ provides S. aureus with phosphodiester-derived nutrients yielding a physiological advantage. Our study demonstrates that GlpQ digests glycerophosphodiester (GPD) headgroups of phospholipids to provide S. aureus with glycerol-3-phosphate (Gro-3P), a readily usable carbon and phosphate source (Watson et al., 1998) . Accordingly, we found that S. aureus could grow in nutrient-poor and phosphate-limited media in the presence of glycerophosphocholine (GroPC) and this property depended largely on GlpQ. This previously unexplored pathway unravels a new strategy that S. aureus uses to acquire nutrients from complex macromolecules enabling the bacteria to survive in different environments.
Results

S. aureus GlpQ hydrolyzes phospholipid head groups
Bacterial glycerophosphodiesterases have been described, yet with different substrate spectra and cellular localization. For example, the cytosolic and periplasmic glycerophosphodiesterase enzymes of Escherichia coli, sharing 30% similarity with the secreted S. aureus
GlpQ have rather broad substrate spectra (Larson et al., 1983 , Ohshima et al., 2008 , while a homologous cytosolic enzyme from Mycoplasma pneumoniae (26% similarity) uses only glycerophosphocholine (GroPC; Schmidl et al., 2011) . To characterize the specificity and activity of the secreted GlpQ from S. aureus the protein was expressed in E. coli without signal peptide and fused to the C-terminus of a maltose-binding protein (MBP) to allow purification. MBP-GlpQ or MBP alone, purified by affinity chromatography to more than 95% purity (Supporting Information Fig. S4 ), were used for activity assays with different substrates. GPDs were prepared from several host-or bacteria-derived glycerophospholipids and GPD hydrolysis by GlpQ was monitored either by the detection of substrate consumption by liquid chromatography coupled to mass spectrometry (LC/MS; Fig. 1 ) or by measuring the formation of Gro-3P in a spectrophotometric assay coupled with Gro-3P dehydrogenase . GlpQ was found to hydrolyse several GPDs including GroPC, glycerophosphoinositol (GroPI), glycerophosphoserine (GroPS), glycerophosphoethanolamine (GroPE), and glycerophosphoglycerol (GroPG; Fig. 1 ). Of note, we did not find other products than Gro-3P in the end reaction analysed by LC/MS discarding the possibility that GlpQ may cleave on both sides of GPD phosphate group. Moreover, GlpQ did not hydrolyse intact glycerophospholipids or bis(4-nitrophenyl) phosphate, a chromogenic substrate of other bacterial phosphodiesterases (Huynh et al., 2015) (data not shown). Thus, S. aureus GlpQ has a broad substrate specificity and phospholipids need to be deacylated before GlpQ can cleave the head group. S. aureus produces the polymeric GPD lipoteichoic acid but this molecule was not degraded by GlpQ (Supporting Information Fig. S5A and S6A ). Likewise, GlpQ did not hydrolyse the S. aureus ribitolphosphate wall teichoic acid polymer (Supporting Information Fig.  S5B and S6B ).
Kinetic analysis of MBP-GlpQ, determined by using commercially available GroPC showed a typical MichaelisMenten hyperbolic response for increasing concentrations of GroPC (Table 1 ; Fig. 2 ). The K m value is in a similar range as those reported for other glycerophosphodiesterases annotated in the Braunschweig Enzyme Database, the most comprehensive online enzyme information system (Chang et al., 2015) , such as the two E. coli enzymes (Larson et al., 1983 , Ohshima et al., 2008 ; Table 1 ). Some described bacterial phosphodiesterases require divalent cations for full activity (Ohshima et al., 2008) and an available crystal structure for S. aureus GlpQ in the protein data base (PDB 2OOG) contains a Zinc ion. S. aureus GlpQ was inactivated by ethylenediaminetetraacetate (EDTA) and by ethylene glycol bis(2-aminoethyl ether)tetraacetic acid (EGTA), and its activity could be rescued by addition of calcium (for EDTA and EGTA) or zinc (only for EDTA) but not of manganese or magnesium ions indicating that GlpQ also requires certain divalent cations ( Fig. 2B and C) .
GlpQ is responsible for extracellular phosphodiesterase activity of S. aureus To analyse if GlpQ is active in culture supernatants and represents the only secreted glycerophosphodiesterase enzyme of S. aureus, glpQ was deleted in several S. aureus strains from different clonal lineages and with different active regulatory systems. All wild-type supernatants showed pronounced phosphodiesterase activity toward GroPC (Fig. 3A) , which was completely abolished in glpQ mutants and this activity could be restored by a plasmid-encoded copy of glpQ (shown for S. aureus 8325-4, Fig. 3B ) demonstrating that GlpQ is the only enzyme responsible for extracellular glycerophosphodiesterase activity of S. aureus. In addition, the data 
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show that GlpQ expression is independent of the Agr or the RsbU regulators, which are non-functional in S. aureus SA113 or 8325-4 and RN1, respectively.
Most coagulase-negative staphylococcal (CoNS) species, except Staphylococcus lugdunensis, Staphylococcus gallinarum, and Staphylococcus pettenkoferi, encode GlpQ-related proteins with signal peptides (Supporting Information Fig. S1 ). However, when supernatants from several staphylococcal species were analyzed for degradation of GroPC, S. aureus exhibited by far the strongest phosphodiesterase activity and many CoNS had no or only weak activity indicating that the extracellular glycerophosphodiesterases from CoNS are either not expressed under in vitro conditions, are not released from the bacterial surface, or have other substrate specificities than S. aureus GlpQ (Fig. 4) .
GlpQ-hydrolyzed phosphodiesters serve as carbon and phosphate sources in nutrient-poor habitats
The reaction catalysed by GlpQ releases Gro-3P, which may serve as a carbon or phosphate source in nutrientpoor surroundings but, to the best of our knowledge, nothing is known about the utilization of GPD metabolites by S. aureus. GPDs can be generated by deacylation of phospholipids via phospholipases (Fig. 9A) . While S. aureus does not secrete such enzymes, host phospholipases may release GDPs from phospholipids. In fact, GroPC has been detected in several human body fluids at rather low concentrations ranging from ca. 1.05 mM (saliva) to 33 mM (blood) (Wishart et al., 2013) . We analyzed the presence of GroPC in human nasal secretions from different donors by LC/MS and detected it at concentrations of up to 5.0 mM, varying strongly (A). The nonlinear Michaelis-Menten curve was determined using Prism v.6 (GraphPad). Error bars represent standard deviation from the mean of nine independent experiments done in triplicate. Effect of divalent cations on MBP-GlpQ (black bars) or MBP negative control (white bars) activities (B, C). Glycerophosphodiesterase activity was measured at pH 9, with 0.5 mM GroPC as substrate in the absence or presence of 5 mM cations and with EDTA (B) or EGTA (C). Error bars represent standard deviations of at least two independent assays done in triplicate.
over time (Supporting Information GlpQ, GroPC was completely degraded indicating that S. aureus GlpQ is active and functional in human body fluids ( Fig. 5 and Supporting Information Fig. S2 ). When GroPC was added as the sole carbon source to the synthetic nasal medium 3 without glucose (SNM3-Glu) recently developed in our laboratory (Krismer et al., 2014) it led to substantially improved growth of S. aureus 8325-4 wild-type ( Fig. 6B and Supporting Information Fig.  S3 , black circles). Similar observations were made with Muller-Hinton broth (MHB), a rather poor complex medium (Fig. 7A) . Notably, the S. aureus glpQ mutant did not profit from the addition of GroPC to MHB (Fig. 7B) or only slightly in SNM3-Glu ( Fig. 6B and Supporting Information Fig. S3 squares) while complementation with a plasmid-encoded glpQ copy restored growth to wild-type levels in both media (Figs. 6E and 7C and Supporting Information Fig. S3 ). The GlpQ product Gro-3P promoted growth in a similar way as GroPC but this effect was independent of GlpQ (Figs. 6C and 7D). Glycerol also promoted growth of wild-type 8325-4 in SNM3-Glu independently of GlpQ (Fig. 6D ). Taken together these data demonstrate that GlpQ enables S. aureus to utilize GroPC as carbon and energy sources under nutrientpoor conditions by releasing Gro-3P, which can be directly used in glycolysis (Fig. 9B) .
Growth of S. aureus is dependent on phosphate (Watson et al., 1998), the concentrations of which also diverges in different parts of the human body. It can be as low as 0.38 6 0.03 mM in human blood (Portale et al., 1987) , 27.9 6 36.0 mM in saliva (Park et al., 2014) or between 0.75 and 7 mM in nasal secretions (Lorin et al., 1972; Burke, 2014) . In such poor environments, Gro-3P generated from GroPC could not only be used as a carbon but also as a phosphate source. To test this hypothesis we prepared SNM3 in which GroPC was added as the only carbon and phosphate source (SNM3-Glu-Pi). Under these conditions, we observed that even 0.1 mM GroPC was sufficient to allow growth of S. aureus (Fig. 8A ), which improved with higher GroPC concentrations. Importantly, the use of GroPC to sustain growth under glucose and phosphate limiting conditions was largely dependent on GlpQ (Fig. 8B ) and this dependency was restored to wild-type levels in a complemented strain (Fig. 8C) . Moreover, GroPC could also rescue S. aureus growth in phosphate-limiting conditions when glucose is present, in a GlpQ-dependent way (Fig. 8D) .
Discussion
Previous studies have emphasized the secretome of S. aureus concerning processes of adhesions, virulence, and immune modulation while a lack of information exists for proteins with putative physiological roles (Somerville and Proctor, 2009; Kusch and Engelmann, 2014) . As a matter of fact, about 50% of the S. aureus secretome remains so far uncharacterized (Kusch and Engelmann, 2014) . It is also well established that the presence and expression level of secreted proteins varies substantially among different S. aureus isolates (Ziebandt et al., 2010) , which may contribute to individual colonization, spreading, and virulence traits. This heterogeneity of the staphylococcal exoproteomes represents an obstacle for the identification of target proteins for protective vaccines (Stentzel et al., 2015) , which are urgently needed as preventive or therapeutic measures against S. aureus infections (Fowler and Proctor, 2014) . Therefore, secreted proteins that belong to the core genome are important to characterize.
Our study focused on GlpQ, a secreted enzyme from S. aureus. Its gene is ubiquitously present in S. aureus genomes suggesting that its function is critical to the bacterial physiology. Indeed, we demonstrate that glyc- erophosphodiesterase activity was present in different S. aureus backgrounds, which was GlpQ-dependent and varied between different strain backgrounds. An increasing number of glycerophosphodiesterases has been identified both in bacteria and eukaryotes with a concomitant variety of roles and substrates (Corda et al., 2014) . The importance of such enzymes for cell physiology has long been underestimated but recently glycerophosphodiesterases are emerging as important physiological enzymes (Corda et al., 2014) and as virulence factors in bacterial pathogens. S. pneumoniae and H. influenzae use GroPC mostly as an essential source for choline, which cannot be synthesized by these bacteria but represents an essential, covalently attached component of their teichoic acids or lipopolysaccharide, respectively, (Fan et al., 2001; Clark and Weiser, 2013) . In contrast, E. coli and other proteobacteria or M. pneumoniae, appear to utilize GPDs as carbon and phosphate source (Ohshima et al., 2008; Schmidl et al., 2011) in a similar way as S. aureus but it remains unclear under which conditions this process may be relevant because many of the reported in vivo concentrations of GPDs are very low. It is possible that the challenging GPD extraction procedure lead to loss and underestimation of the actual in-vivo concentrations.
Moreover, GPD concentrations seem to differ largely for different tissues and mammalian species (Garcia-Perez and Burg, 1991; Gallazzini et al., 2008; Kopp et al., 2010; Wishart et al., 2013) and to fluctuate probably as a result of differences in individual diets, lifestyles or health status (Lin et al., 2012) . Thus, the capacity to utilise GroPC may be important only under certain specific conditions. Even low GroPC amounts may be important for S. aureus metabolism, for example, when glucose concentrations dwindle and reach only low micromolar concentrations as described recently (Krismer et al., 2014) or when phosphate becomes limiting (Fig. 8 ).
Comprehensive and advanced metabolomics studies will be necessary to clarify these questions in the future.
The substrate specificities of bacterial glycerophosphodiesterases has not been studied in detail with the exception of periplasmic and cytoplasmic E. coli glycerophosphodiesterases, which have a broad range of activities for different GPDs (Larson et al., 1983; Ohshima et al., 2008) . In our study, we found that S. aureus GlpQ has a broad substrate specificity that reflects probably the GPD substrates available in S. aureus habitats. GroPC has been found to be by far the dominant GPD among the various phospholipid head groups in human materials suggesting that it may be the major GlpQ Fig. 6 . Glycerophosphocholine is a carbon source for S. aureus growth in synthetic nasal medium without glucose (SNM3-Glu). S. aureus 8325-4 wild-type (•, ᭺ ) or glpQ mutant strain (,w) were grown in SNM3-Glu without (empty markers) or with (full markers) 10 mM of different carbon sources: glucose (A), GroPC (B), Gro-3P (C), or glycerol (D). Impaired growth of glpQ mutant strain is restored to wild-type levels in a mutant strain with a plasmid-encoded glpQ (᭜; E). Means and standard deviations of at least two independent experiments are shown. Significant differences for the 32 h time point between growth without and with GroPC (B) or wild-type and mutant (E) were calculated with Student's t test. *, p < 0.05; ***, p < 0.001; n.s.: nonsignificant.
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substrate. Our finding that GroPC supports growth of S. aureus suggests that such molecules have been overlooked and neglected as potential microbial nutrients in the past (Fig. 9B) .
S. aureus encodes two further membraneassociated potential glycerophosphodiesterases, which could also be involved in GroPC degradation, being the reason for the residual growth-promoting impact of GroPC in SNM3-Glu on the S. aureus glpQ mutant (Fig. 6B) . However, transposon mutants of the two membrane-anchored glycerophosphodiesterases showed no growth defect in SNM3-Glu when GroPC was the sole carbon source (data not shown), suggesting that the secreted GlpQ is a major enzyme for the cleavage of GPDs. Transporters for Gro-3P have been described in S. aureus, GlpT, and UgpT, (Park et al., 2015) , which may accomplish the uptake of Gro-3P upon GlpQ-mediated release from GPDs. GroPC transporters have been described in other bacteria and the potential existence of such a transporter in S. aureus might enable the use of GroPC in SNM3-Glu media to some degree, even when GlpQ is not present.
It is still unclear why most of the other tested staphylococcal species exhibited no or only very low GroPChydrolyzing activity in culture filtrates despite the presence of signal peptides-bearing GlpQ homologs in their genomes. Several of these enzymes seem to have additional domains between the signal peptide and the enzymatic domain that are absent from S. aureus GlpQ (Supporting Information Fig. S1 ). Such domains may retain the proteins in the cell envelope or alter the substrate spectrum. The particularly high GPD-degrading activity might be a fitness advantage in competition with CoNS contributing to the specific niche adaptation or it might promote the capacity of S. aureus to infect certain tissues. Fig. 7 . Growth of S. aureus 8325-4 wild-type (A) or glpQ-complemented strain (C) but not glpQ mutant (B) is improved by GroPC in MHB medium. S. aureus was grown in MHB (᭺) or MHB complemented with 10 mM GroPC (w) (A-C). Gro-3P improves growth of S. aureus wildtype (, w ) and glpQ mutant (•, ᭺ ) strains in MHB (D). Strains were grown in MHB (empty symbols) or MHB complemented with 10 mM Gro-3P (full symbols) (D). Means and standard deviations of at least two independent experiments are shown. Significant differences for the 10 and 12 h time points between growth without and with GroPC (A-C) were calculated with Student's t test. *, p < 0.05; **, p < 0.01; n.s.: nonsignificant.
Our finding that GlpQ is a glycerophosphodiesterase enzyme that contributes to the utilization of specific metabolites acquired from the environment (Fig. 9B) contributes to unravelling the core secretome of S. aureus and further emphasizes the importance of understanding the sources of nutrition by S. aureus while inhabiting and infecting the human host.
Experimental procedures
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in Supporting Information Table S1 . E. coli was grown in Luria Broth (LB; 1% tryptone, 0.5% yeast extract, and 0.5% NaCl) supplemented with 100 lg ml 21 of ampicillin and with 0.2% glucose for the overexpression of MBP-GlpQ.
S. aureus was grown in MHB (Carl Roth; 0.2% beef extract, 1.75% acid hydrolysate of casein, 0.15% starch) or in basic medium (BM; 1% tryptone, 0.5% yeast extract, 0.5% NaCl, 0.1% K 2 HPO 4 , and 0.1% glucose) at 378C with shaking at 160 rpm. For growth in defined conditions the synthetic nasal medium SNM3 (Krismer et al., 2014) without the iron-complexing agent 2, 2 0 -bipyridine was used. SNM3 was prepared without a carbon source (SNM3-Glu) or complemented with 10 mM glucose, 10 mM GroPC, 10 mM Gro-3P, or 10 mM glycerol. For phosphate limiting growth conditions, SNM3-Glu was prepared without phosphate buffer (SNM3-Glu-Pi). The pH of the different SNM3 media was pH 6. For growth curves, bacteria from overnight cultures grown in MHB were centrifuged, washed two times with SNM3-Glu or SNM3-Glu-Pi, reinoculated in fresh SNM3-Glu or SNM3-Glu-Pi to an initial OD 600 nm of 0.05 in microtiter plates, and grown in a TECAN Infinite 200 PRO reader (Tecan Group, Switzerland) or in an Epoch2 BIO-TEK reader, with orbital shaking (180 rpm) at 378C with measurement of optical densities each 15 min.
Construction of plasmids and strains
Primers used in this study are listed in Supporting Information Table S2 . Heterologous expression of GlpQ was accomplished by fusing GlpQ to the C-terminal end of the E. coli MBP. The glpQ gene without its signal peptide was amplified from S. aureus 8325-4 genomic DNA with primer pair gib_pMal_glpQ_f/gib_pMal_glpQ_r and the vector pMAL-c5X was amplified with primers gib_uni_pMalc5x_r and gib_uni_pMalc5x_f. The resulting PCR products were joined using Gibson cloning (Gibson et al., 2009 ) creating plasmid pMAL-glpQ where the glpQ gene was in frame with the malE gene. pMAL-glpQ was used to transform E. coli DH5a and the correct insertion of glpQ was confirmed by sequencing. Fig. 8 . GroPC is a carbon and phosphate source for S. aureus 8325-4 growth in synthetic nasal medium SNM3-Glu-Pi (A). S. aureus 8325-4 wild-type (A) or glpQ mutant strain (B) was grown in SNM3-Glu-Pi with different concentrations of GroPC as the only carbon and phosphate source. Impaired growth of glpQ mutant strain () in SNM3-Glu with 0.1 mM GroPC is restored to wild-type (•) levels in a mutant strain with a plasmid-encoded glpQ (᭜, C). GroPC enables S. aureus to grow in SNM3-Pi media in the absence of phosphate (D). S. aureus wild-type (•, ᭺ ), glpQ mutant (,w), or complemented (᭜,᭛) strains were grown in SNM3-Pi with 2 mM glucose and with (full markers) or without (empty markers) 10 mM GroPC as the only phosphate source. Means and standard deviations of at least two independent experiments are shown. For construction of the markerless DglpQ mutant in the different S. aureus strains, the E. coli-S. aureus shuttle vector pBASE6 was used. The flanking regions of glpQ were amplified from S. aureus 8325-4 genomic DNA with primer pairs UPGlpQ_P1/GlpQ_P4 or GlpQ_P5/DownGlpQ_P1 and both PCR products were used as template for a second PCR product using primer pair UPGlpQ_P1/DownGlpQ_P1. After digestion of the last PCR product with EcoRI/BglII the fragment was ligated into pBASE6 vector previously digested with EcoRI and BglII and used to transform E. coli DC10B (Monk et al., 2012) . The resulting plasmid pnullglpQ was isolated, the cloned region was sequenced and the plasmid was directly transferred by electroporation to the different S. aureus strains, where the homologous recombination process resulted in substitution of the glpQ gene with the ATGTAA sequence. Mutants were confirmed by PCR analysis and sequencing of the glpQ flanking region.
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To complement the glpQ mutant strains the pT181 vector was reconstructed from the S. aureus plasmid pTX15 by deletion of the xylose promoter and the lipase gene with PstI and SmaI restriction enzymes. The resulting vector was filled with Klenow fragment, religated, and renamed pT. The glpQ gene including the promoter region was amplified from S. aureus 8325-4 genomic DNA with the primer pair UP_glpQ_P3/DOWN_glpQ_P3, digested with PstI and SmaI enzymes and ligated into the previously digested pT vector with the same restriction enzymes. The ligation product was concentrated and directly introduced into the S. aureus recipient strain 8325-4 DglpQ by electroporation. The empty vector pT was electroporated into S. aureus 8325-4 and 8325-4 DglpQ as control. The plasmids pT and pT-glpQ Fig. 9 . Schematic representation of the cleavage site for phospholipases PLA 1 and PLA 2 in the phospholipid phosphatidylcholine generating free fatty acids (FFA) and sn-glycero-3-phosphocholine (GroPC) (A). GroPC is available in human body fluids colonized by S. aureus. Secreted GlpQ cleaves the glycerophosphate bond releasing an alcohol and glycerol-3-phosphate (Gro-3P), which can be used by S. aureus as a phosphate, carbon, and energy source and in many physiological processes.
were extracted from their recipient strains and the cloned region was confirmed by sequencing.
Purification of MBP-GlpQ
For heterologous expression of MBP-GlpQ, E. coli BL21(DE3) competent cells were transformed with pMALglpQ. Cells were grown in LB with 0.2% glucose to an OD 600nm of 0.5. Expression of MBP-GlpQ was induced with 0.3 mM isopropylthiogalactoside and cells were further grown for 16 h at 308C. Cells were lysed with 0.4 mg/ml lysozyme and by sonication. The lysate was purified by affinity chromatography using amylose resin (Qiagen) and 20 mM Tris-HCl pH 7.6, 200 mM NaCl as washing buffer. MBP-GlpQ was eluted with the same buffer but using 20 mM NaCl and 10 mM maltose. Purity of the protein was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and protein concentration was measured using the Bradford Protein Assay (BioRad) using bovine serum albumin as the standard.
Preparation of substrates
GroPC and GroPI were acquired from Santa Cruz Biotechnology and Echelon Biosciences, respectively. PG, PS, and PE phospholipids were purchased from Avanti Polar Lipids. GroPG, GroPS, and GroPE were obtained via deacylation of the corresponding phospholipids PG, PS, and PE by mild alkaline hydrolysis according to (Kopp et al., 2010) . Briefly, 25 mg of each phospholipid was dissolved in 3 ml CHCl 3 :CH 3 OH (2:1) and hydrolyzed with 1 ml of 2 N NaOH, at room temperature for 2 h. The complete degradation of phospholipids was controlled by thin-layer chromatography. The reaction was neutralized with 1 ml HCl and GPDs were extracted twice with 2 ml of water and washed with 2 ml CHCl 3 . Samples were stored at 48C.
Human nasal secretions were collected from healthy volunteers. Different batches of pooled human serum were purchased from the Centre for Clinical Transfusion Medicine, Tuebingen, Germany. Samples were cleared from proteins with the same volume of ice-cold CH 3 OH:H 2 O (80:20) . Supernatants containing the substrates were dried with a SpeedVac at 308C, resuspended in H 2 O, and directly used for LC/MS analysis.
Enzyme activity assay
Culture supernatants were collected after 18h post inoculation from 20-ml S. aureus cultures grown in MHB or BM media in 125-ml baffled flasks with shaking at 160 rpm at 378C. After adjusting the final OD at 600nm to 1.5 or 3.0, the culture supernatants were filtered through a 0.2-lm pore size filter (Millipore) and immediately used.
Enzyme activity kinetic was followed by an enzymecoupled spectrophotometric assay measuring the amount of Gro-3P generated by the glycerophosphodiesterase reaction. The assay mixture was performed in a 96-well plate in a final volume of 50 ml. The optimal pH of the reaction was first tested using different buffers for 1 mg MBPGlpQ and 0.5 mM GroPC. The optimized reaction contained 0.9 M hydrazine-glycine buffer pH 9, 0.5 mM NAD, 10 U/ml Gro-3P dehydrogenase (Sigma), and 5 ml culture supernatant or 0.5 to 1 mg purified MBP-GlpQ or MBP. Different amounts of substrates were added from 0.05 to 2 mM. The influence of CaCl 2 , MnCl 2, MgCl 2 , and ZnCl 2 on the activity of GlpQ was tested at 1-5 mM for each divalent cation. The kinetic of the reaction was measured until oxidation of Gro-3P by Gro-3P dehydrogenase was complete and the Gro-3P concentration was calculated from the absorbance change at 340 nm using a NADH standard curve. The kinetic data were analyzed using Prism 6 software (GraphPad).
End point enzyme activity was analyzed by the detection of the GPDs' signal by LC/MS. Reaction mixtures contained 20 mM Tris-HCl pH 8.0, 5 mM CaCl 2 , 0.5 to 1 mg purified MBP-GlpQ or MBP and 1 mM of each GPD. A blank control without enzyme was also included. Reaction mixtures were incubated at room temperature for 10 min and analysed by LC/MS. Teichoic acids were also evaluated as substrates for MBP-GlpQ by LC/MS. Extracted LTA (20 ml) or WTA (5 mM) were incubated for 1 or 16 h with 5 mg purified MBP-GlpQ in 20 mM Tris-HCl pH 8.0 with 5 mM CaCl 2 before LC/MS analysis.
Extraction of teichoic acids from S. aureus cells
Cell-associated LTA was extracted essentially as described in (Fedtke et al., 2007) from 50 ml overnight grown bacteria in BM supplemented with 0.35% glucose. To test if LTA was degraded by MBP-GlpQ, extracted LTA was dried in a speed vac and resuspended in 20 mM Tris-HCl pH 6 or pH 8. Different amounts of extracted LTA, 0.1 or 1 ml were incubated without or with 1 mg of purified MBP-GlpQ or MBP as a negative control, for 30 min or 16 h at room temperature. Samples were run in a SDS-PAGE 12% and proteins and LTA were transferred to a PFDV membrane (Millipore), blocked with 5% milk in PBS-tween 0.5% (PBS-T), incubated with anti-LTA or anti-MBP (New England Biolabs) primary antibodies diluted in PBS-T and with the secondary antibody anti-mouse DyLight 680. LTA and MBP tagged GlpQ were detected in a Licor Odyssey CLx instrument.
Extraction of wall teichoic acids from S. aureus cells and WTA-PAGE analysis was performed as previously described (Winstel et al., 2014) .
LC/MS analysis of GlpQ substrates
Substrates GroPC, GroPI, GroPS, GroPE, and GroPG incubated in the presence or absence of MBP-GlpQ or MBP (negative control), as well as blood serum and nasal samples were analysed by HPLC/MS by using an Ultimate 3000 HPLC system (Dionex) connected to a MicrOTOF II detector (Bruker). Sample ionization was achieved via electrospray ionization in positive ion mode. LC was performed with a Gemini C18 column (150 3 4.6 mm, 110 Å , 5 lM; Phenomenex) at 378C and a flow rate of 0.2 ml/min. A 45-min program was applied: 5 min washing step with 96% buffer A (0.1% formic acid with 0.05% ammonium formate), followed by a 30-min linear gradient from 4 to 40% buffer B Staphylococcus aureus uses GPDs 239 (100% acetonitrile). A 5-min 40% buffer B step and a 5-min re-equilibration step (100% buffer A) completed the method. Exact masses in positive ion mode for GroPC (m/z 11 258.10), GroPI (m/z 11 357.05), GroPS (m/z 11 260.05), GroPE (m/z 11 216.06), and GroPG (m/z 11 247.05) were presented as extracted ion chromatograms (EIC) with Data Analysis (Bruker), exported and illustrated with Prism 6.0 (GraphPad). The peak areas of GroPC in nasal samples were quantified with dilution series of GroPC (m/z 11 258.10) with Prism 6.
Statistical methods
Statistical analyses were performed with the Prism 6.0 package (GraphPad Software) and the between-group differences were analyzed for significance with the two-tailed Student's t test. A P value of 0.05 was considered statistically significant.
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